$16.23
-0.17-1.04%
Last update: Nov 11, 9:30 AM
Jade Biosciences Inc
JBIONASDAQ
Jade Biosciences rose 67.3% from $9.80 to $16.40, ahead of the S&P 500's +9.8%. Its worst day was Apr 29 (−15.6%), and its low came Nov 13 at $9.68.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.48 beat the $-0.63 estimate on $0.00 revenue.
−3.2% · S&P 500 −1.7%
EPS of $-0.11 beat the $-0.46 estimate on $0.00 revenue.
Story events cover the past 12 months · Times ET
+1.2% · S&P 500 −1.3%
Jade Biosciences shares rose 14.0%, while the S&P 500 rose 0.8%.
+14.0% · S&P 500 +0.8%
Jade Biosciences shares rose 13.6%, while the S&P 500 rose 0.2%.
+13.6% · S&P 500 +0.2%
Jade Biosciences closed at its highest level of the year, 174.0% above where the year started.
+7.5% · S&P 500 +0.2%
EPS of $-0.57 missed the $-0.49 estimate on $0.00 revenue.
+6.6% · S&P 500 +0.8%
Jade Biosciences shares fell 11.6%, while the S&P 500 rose 0.3%.
−11.6% · S&P 500 +0.3%
Jade Biosciences shares rose 15.6%, while the S&P 500 fell 0.3%.
+15.6% · S&P 500 −0.3%
EPS of $-0.76 missed the $-0.57 estimate on $0.00 revenue.
−1.0% · S&P 500 0.0%
Jade Biosciences shares fell 12.2%, while the S&P 500 fell 0.7%.
−12.2% · S&P 500 −0.7%
Where it ended: a close of $16.40 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.78).
Nothing in the past 12 months.
All JBIO dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for JBIO and SPY from Benzinga historical bars. Not investment advice.
